Sunshine Biopharma (SBFM) Change in Account Payables (2010 - 2019)
Sunshine Biopharma (SBFM) posted Change in Account Payables of $33797.0 for Q4 2019, up 260.63% on a QoQ basis from -$21040.0 in Q3 2019, and down 19.32% year-over-year from $41891.0 in Q4 2018.
Sunshine Biopharma (SBFM) Change in Account Payables (2010 - 2019) Analysis & Trends
Sunshine Biopharma's Change in Account Payables history runs 10 years deep, the most recent figure standing at $33797.0 for Q4 2019.
- Quarterly Change in Account Payables fell 19.32% year-over-year to $33797.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was -$18692.0 (down 151.21% YoY) and the FY2020 annual result came in at -$35012.0, down 87.31% from the prior year.
- Change in Account Payables was $33797.0 for Q4 2019 at Sunshine Biopharma, up from -$21040.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $342944.0 in Q2 2017 and bottomed at -$359099.0 in Q3 2017.
- A 5-year average of -$3273.6 and a median of -$171.0 in 2017 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2018 — Change in Account Payables plunged 6587.13% — and 2019, when it surged 18113.93%.
- Sunshine Biopharma's Change in Account Payables stood at $11953.0 in 2015, then soared by 132.57% to $27799.0 in 2016, then tumbled by 41.27% to $16326.0 in 2017, then soared by 156.59% to $41891.0 in 2018, then dropped by 19.32% to $33797.0 in 2019.
- Business Quant data shows SBFM's Change in Account Payables at $33797.0 in Q4 2019, -$21040.0 in Q3 2019, and $21977.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 30.60 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 32.70 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Sunshine Biopharma | 750,608.81 | -6.16 Mn | 2.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 33,797.00 |
| Dec 31, 2019 | 33,797.00 |
| Sep 30, 2019 | -21,040.00 |
| Sep 30, 2019 | -21,040.00 |
| Jun 30, 2019 | 21,977.00 |
| Jun 30, 2019 | 21,977.00 |
| Mar 31, 2019 | -53,426.00 |
| Mar 31, 2019 | -53,426.00 |
| Dec 31, 2018 | 41,891.00 |
| Dec 31, 2018 | 41,891.00 |
| Sep 30, 2018 | 6,166.00 |
| Sep 30, 2018 | 6,166.00 |
| Jun 30, 2018 | -122.00 |
| Jun 30, 2018 | -122.00 |
| Mar 31, 2018 | -11,435.00 |
| Mar 31, 2018 | -11,435.00 |
| Dec 31, 2017 | 16,326.00 |
| Dec 31, 2017 | 16,326.00 |
| Sep 30, 2017 | -359,099.00 |
| Sep 30, 2017 | -359,099.00 |